Cost-effectiveness analysis of capecitabine versus active monitoring in stable or responding metastatic colorectal cancer after 16 weeks of first-line therapy
Background This study aimed to assess the cost-effectiveness of capecitabine versus active monitoring in stable or responding metastatic colorectal cancer (mCRC) after 16 weeks of first-line therapy.Methods A partitioned survival model (PSM) was constructed to determine the costs and effects of cape...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2529573 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!